المؤلفون: Hajime Nagasu (5814773), Yuichiro Yano (610246), Hiroshi Kanegae (11326888), Hiddo J.L. Heerspink (9636378), Masaomi Nangaku (313494), Yosuke Hirakawa (11326890), Yuka Sugawara (10896313), Naoki Nakagawa (648870), Yuji Tani (11326891), Jun Wada (25812), Hitoshi Sugiyama (175775), Kazuhiko Tsuruya (636724), Toshiaki Nakano (27092), Shoichi Maruyama (363455), Takashi Wada (187967), Kunihiro Yamagata (413551), Ichiei Narita (156924), Kouichi Tamura (168103), Motoko Yanagita (134965), Yoshio Terada (494308), Takashi Shigematsu (829751), Tadashi Sofue (9142866), Takafumi Ito (3279699), Hirokazu Okada (323221), Naoki Nakashima (3072033), Hiromi Kataoka (381574), Kazuhiko Ohe (49207), Mihoko Okada (9142869), Seiji Itano (5184170), Akira Nishiyama (167531), Eiichiro Kanda (52677), Kohjiro Ueki (127501), Naoki Kashihara (3161976)

مصطلحات موضوعية: Clinical Sciences not elsewhere classified, Kidney Disease, SGLT2 inhibitor, Renal Registry, Drug Management, Asian(s)

Relation: https://figshare.com/articles/figure/Kidney_Outcomes_Associated_With_SGLT2_Inhibitors_Versus_Other_Glucose-Lowering_Drugs_in_Real-world_Clinical_Practice_The_Japan_Chronic_Kidney_Disease_Database/16434609

الاتاحة: https://doi.org/10.2337/figshare.16434609.v1